Index Ventures has closed its latest fund Index Ventures Growth I LP on EUR 400m. The fund was formed to address the market opportunity created by the maturation of Europe’s start-up industry and the movement of traditional late-stage investors into larger deal sizes in both the technology and life science sectors. The new fund will complement the firm’s venture capital fund, Index Ventures IV LP, which will continue to focus primarily on seed and early-stage investments. The fund expects to make investments of between EUR 20m and EUR 50m in European-based companies. The team will also selectively consider companies in Eastern Europe and the US that have plans to expand internationally. Technology and life science companies are the primary focus, with media, retail and green technology opportunities also being considered.
Charcoal and natural additives company saw final bids from two banks and one direct lender
VCs including the Swiss Entrepreneurs Fund, BtoV and Ringier Digital Ventures also participated
Around 40 existing and new LPs, including British Patient Capital and the EIF, participated
Fund will invest in buyouts, recapitalisations and carve-outs of both profitable and underperforming businesses